Evidence map›Paper›PMID 40662187›Full record

ArticleCase reports in oncology

Remarkable Response to Cisplatin-Based Chemotherapy and Long-Term Remission in a Young Male with Widespread Extragonadal Choriocarcinoma: A Case Report and Literature Review.

Abdulmajeed Alshabanat, Waad Aldahlawi, Siham Hussein, Wajd Althakfi, Ahmed Ibrahim

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdulmajeed AlshabanatDepartment of Medicine, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.
Waad AldahlawiDepartment of Medicine, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.
Siham HusseinDepartment of Medicine, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.
Wajd AlthakfiDepartment of Pathology, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.
Ahmed IbrahimDepartment of Oncology, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Choriocarcinoma is a rare and aggressive germ cell tumor that presents significant diagnostic challenges, particularly in males, where it is typically found in the gonads. Most patients present with advanced disease, often exhibiting symptoms related to metastatic spread, such as shortness of breath, cough, and hemoptysis. The rarity of extragonadal choriocarcinoma and its non-specific presentation make early diagnosis difficult, emphasizing the need for a multidisciplinary approach to treatment. Case Presentation: A 31-year-old male presented with progressive shortness of breath, cough, and hemoptysis for over a month. Initial imaging revealed multiple pulmonary nodules and a large necrotic retroperitoneal mass, along with liver metastases. The patient's β-human chorionic gonadotropin (β-hCG) levels were markedly elevated, raising suspicion of choriocarcinoma, subsequently confirmed through biopsy. Given the rapid clinical deterioration, chemotherapy with cisplatin and etoposide was initiated. The patient responded well to treatment, with a significant reduction in tumor and metastasis size. Over 30 months of follow-up, the patient showed continued clinical improvement with no evidence of disease recurrence. Conclusion: Extragonadal choriocarcinoma is a highly aggressive and rare malignancy that poses significant diagnostic and therapeutic challenges. This case underscores the importance of early intervention and the need for ongoing research to improve outcomes in these patients. A multidisciplinary approach is crucial for optimal management.

Indexed as

ChoriocarcinomaHuman chorionic gonadotropinMale choriocarcinomaMetastasisPrognosis

Identifiers

PMID40662187
PMCPMC12258871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.